SharpCharts

CVS offers high risk/reward entry

看多
SharpCharts 已更新   
NYSE:CVS   CVS Health Corporation
FA wise, CVS is not a terrible stock. The company has been making consistently increasing both in revenues and earnings the last few years. My stock valuation system gives it good scores both in valuation and quality domains.

TA wise, the low of $60 at end of March confluently hit the big support trend line and 61.8% fib level and bounced off strongly in 5 waves from there. All of that offers a very promising entry point around $64 level. Latest earnings call which is considered as negative offers us a nice pull back from the last 5-wave bounce taking price right to ~$64 level.

Conservative target: $80 (green box). This is also an important POC level in weekly chart.

Reasonable target: $90 (blue box). This is a reasonable level for the next considerable retracement.

Stop loss: below 60.


{
"info": {
"close": 64.47,
"marketcap ($bil)": 67.1,
"name": "cvs health corporation",
"sector": "health care",
"industry": "medical/nursing services",
"country": "united states"
},
"val": {
"peg_k": 0.40787581,
"fp2e_k": 10.12087912,
"p2e_k": 10.01086957,
"p2e": 9.99534884,
"p2bv": 1.7412767,
"p2sales": 0.35731722,
"p2fcf": null,
"ev2ebitda": null,
"ev2ebitda_k": null
},
"val2_k": 30,
"val2_q": 19,
"qual2_k": 55,
"qual2_q": 38,
"qual3_k": 55
}
評論:
評論:
FA wise, CVS is pretty solid stock.

lh3.googleuserconten...YCw/h743/Capture.PNG
交易進行:
Added more call options when price around 60.50.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。